Mode
Text Size
Log in / Sign up

Radium-223 Dichloride

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials of Radium-223 Dichloride

8 trials tracked of Radium-223 Dichloride.

8Trials tracked
0Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 2 7 Other / NA 1
  1. Phase 2 Study Evaluating the Addition of Pembrolizumab to Radium-223 in mCRPC Completed
  2. Phase 2 Study of Sipuleucel-T W/ or W/O Radium-223 in Men With Asymptomatic or Minimally Symptomatic Bone-MCRPC Completed
  3. Phase 2 Non-Randomized Trial Assessing Pain Efficacy With Radium-223 in Symptomatic Metastatic Castration-Resistant Prostate Cancer Completed
  4. Phase 2 RAdium-223 and SABR Versus SABR for Oligometastatic Prostate Cancers Completed
  5. Phase 2 A Biomarker Study of Standard-of-care Radium-223 Chloride for Metastatic Castration-resistant Prostate Cancer Completed
  6. Phase 2 Prostate Cancer Intensive, Non-Cross Reactive Therapy (PRINT) for Castration Resistant Prostate Cancer (CRPC) Completed
Show 2 more trials
  1. Phase 2 Trial of Rad-223 Activity in Asymptomatic Patients With mCRPC While on Abiraterone or Enzalutamide Besides AR-V7 Status Completed
  2. N/A Real World Evidence Study on Metastatic Prostate Cancer in the Pirkanmaa Hospital District in Finland Completed

Showing the 8 most-cited and recently-updated of 8 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.